Specializing in biopharmaceutical analysis, Damien Mouvet has over 25 years of expertise in analytical development, nanomedicines, and regulatory quality. He is skilled in biomolecule characterization strategies, quality control, and the implementation of advanced analytical methods for oligonucleotides, mRNA, and viral vectors.

• Biopharmaceuticals
• Analytical Development
• Nanomedicines
• Biomolecule Characterization
• Quality Control